|
 |
|
|
| |
|
|
|
|
| TABLE (Revised). Estimated percentage* of injecting-drug users (IDUs) engaging in selected behaviors associated with human immunodeficiency virus (HIV) infection in the preceding 12 months,† by sex, race/ethnicity, and age group—National HIV Behavioral Surveillance System, 23 cities,§ United States, May 2005 – February 2006. |
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Characteristic |
Shared syringes |
|
Shared injection equipment |
|
Had vaginal sex |
|
Had unprotected vaginal sex |
|
Had more than one opposite-sex partner |
|
Tested for HIV infection |
|
Participated in HIV behavioral intervention |
|
Tested for hepatitis C |
%
(SE¶)
|
|
%
(SE)
|
|
%
(SE)
|
|
%
(SE)
|
|
%
(SE)
|
|
%
(SE)
|
|
%
(SE)
|
|
%
(SE)
|
| Overall |
32.8
(0.9) |
|
58.5
(1.0) |
|
82.4
(0.8) |
|
63.4
(1.0) |
|
47.8
(1.0) |
|
66.3
(0.9) |
|
29.7
(0.9) |
|
72.7
(0.9) |
| Sex |
| Men |
33.1
(1.1) |
|
58.9
(1.2) |
|
83.5
(0.9) |
|
63.6
(1.2) |
|
51.7
(1.1) |
|
64.4
(1.1) |
|
28.5
(1.0) |
|
74.4
(1.0) |
| Women |
32.4
(1.6) |
|
57.6
(1.9) |
|
80.3
(1.5) |
|
62.9
(1.8) |
|
40.1
(1.6) |
|
69.8
(1.6) |
|
32.3
(1.7) |
|
69.5
(1.7) |
| Race/
Ethnicity |
| White, non-Hispanic |
41.1
(1.7) |
|
65.9
(1.7) |
|
82.0
(1.3) |
|
65.0
(1.7) |
|
48.6
(1.8) |
|
62.4
(1.7) |
|
23.4
(1.5) |
|
75.8
(1.5) |
| Black, non-Hispanic |
29.9
(1.2) |
|
55.8
(1.4) |
|
85.5
(1.0) |
|
65.1
(1.3) |
|
52.5
(1.3) |
|
66.2
(1.2) |
|
31.1
(1.2) |
|
69.2
(1.2) |
| Hispanic |
30.1
(2.1) |
|
56.7
(2.5) |
|
77.3
(2.3) |
|
58.7
(2.5) |
|
39.1
(2.3) |
|
70.2
(2.1) |
|
33.3
(2.2) |
|
75.1
(2.1) |
| Other** |
37.5
(5.0) |
|
63.5
(4.8) |
|
82.5
(3.4) |
|
60.2
(4.6) |
|
49.2
(5.3) |
|
64.0
(4.5) |
|
35.1
(5.1) |
|
78.5
(3.9) |
| Age Group (yrs) |
| 18-24 |
45.4
(4.8) |
|
70.5
(4.3) |
|
88.7
(2.6) |
|
68.4
(3.9) |
|
60.3
(4.4) |
|
72.6
(3.3) |
|
24.4
(4.7) |
|
66.0
(4.1) |
| 25-34 |
40.2
(2.3) |
|
63.0
(2.3) |
|
87.6
(1.6) |
|
65.5
(2.4) |
|
58.9
(2.0) |
|
70.2
(1.8) |
|
29.9
(2.2) |
|
69.0
(2.1) |
| 35-44 |
33.1
(1.6) |
|
59.9
(1.8) |
|
84.4
(1.5) |
|
67.5
(1.7) |
|
48.8
(1.7) |
|
67.4
(1.6) |
|
32.5
(1.7) |
|
67.9
(1.8) |
| 45-54 |
33.0
(1.4) |
|
58.5
(1.6) |
|
80.8
(1.3) |
|
62.8
(1.6) |
|
44.7
(1.6) |
|
63.6
(1.5) |
|
29.9
(1.4) |
|
77.7
(1.4) |
| 55 |
24.9
(2.5) |
|
51.7
(3.0) |
|
71.1
(2.8) |
|
49.6
(2.7) |
|
37.7
(2.8) |
|
65.1
(2.8) |
|
24.3
(2.4) |
|
79.9
(2.1) |
|
| |
|
 |
|
| * |
Percentages were weighted to adjust for differences in recruitment, the size of participant IDU peer networks, and the size of the IDU population in each city. |
| † |
Sharing syringes was defined as “using needles that might have already been used by someone else,” and sharing injection equipment was defined as using equipment such as cookers, cottons, or water used to rinse needles or prepare drugs “that someone else used.” Unprotected vaginal sex was defined as “sex without a condom.” Persons tested for HIV infection include those with results that were negative, indeterminate, or unknown. Participating in an individual or group HIV behavioral intervention did not include counseling received as part of an HIV test. Testing for hepatitis C virus infection was measured as ever tested or ever received a diagnosis of hepatitis C. |
|
§ |
Atlanta, Georgia; Baltimore, Maryland; Boston, Massachusetts; Chicago, Illinois; Dallas, Texas; Denver, Colorado; Detroit, Michigan; Fort Lauderdale, Florida; Houston, Texas; Las Vegas, Nevada; Los Angeles, California; Miami, Florida; Nassau-Suffolk, New York; New Haven, Connecticut; New York, New York; Newark, New Jersey; Norfolk, Virginia; Philadelphia, Pennsylvania; San Diego, California; San Francisco, California; San Juan, Puerto Rico; St. Louis, Missouri; and Seattle, Washington. |
| ¶ |
Standard error. |
| ** | Includes American Indian/Alaska Natives, Asians, Native Hawaiian or other Pacific Islanders, persons of multiple race, and those for whom race/ethnicity information was missing. |
|
Back
|
|
|
|
|
|
|
|
|
